syndrome	score	normalized_score
BARBER-SAY SYNDROME; BBRSAY	1.0	100.0
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	100.0
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.60896505	60.896505
DEXTROCARDIA	0.500545554	50.0545554
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.5	50.0
MALIGNANT ATROPHIC PAPULOSIS	0.5	50.0
SARCOIDOSIS	0.5	50.0
EARLY-ONSET SCHIZOPHRENIA	0.45704225000000004	45.704225
7Q11.23 MICRODUPLICATION SYNDROME	0.3951868	39.51868
11Q22.2Q22.3 MICRODELETION SYNDROME	0.351422454	35.1422454
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.35063205	35.063204999999996
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.35063205	35.063204999999996
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.35063205	35.063204999999996
PLACENTAL INSUFFICIENCY	0.34037525	34.037525
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.333878554	33.3878554
POTOCKI-SHAFFER SYNDROME	0.333878554	33.3878554
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	33.3333
XK APROSENCEPHALY SYNDROME	0.333333	33.3333
ZIMMERMANN-LABAND SYNDROME	0.333333	33.3333
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	33.3333
WAGR 11P13 DELETION SYNDROME	0.333333	33.3333
ESOPHAGEAL ATRESIA	0.333333	33.3333
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.27563205	27.563205000000004
AUTISM	0.27563205	27.563205000000004
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.27563205	27.563205000000004
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.27563205	27.563205000000004
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.27563205	27.563205000000004
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.27563205	27.563205000000004
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.2685898	26.85898
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.25740741	25.740741
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.25	25.0
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.23528840000000004	23.528840000000002
COWDEN SYNDROME	0.174254804	17.4254804
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.166667	16.666700000000002
CONGENITAL PRIMARY MEGAURETER	0.166667	16.666700000000002
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.166667	16.666700000000002
CAUDAL DUPLICATION	0.166667	16.666700000000002
ULBRIGHT-HODES SYNDROME	0.166667	16.666700000000002
ADNP SYNDROME	0.14015571	14.015571
ALSTRÖM SYNDROME	0.132587804	13.258780400000001
TOXIC EPIDERMAL NECROLYSIS	0.125	12.5
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 17-BETA-HYDROXYSTEROID DEHYDROGENASE 3 DEFICIENCY	0.125	12.5
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.125	12.5
STEVENS-JOHNSON SYNDROME	0.125	12.5
INTERSTITIAL CYSTITIS	0.125	12.5
FOWLER URETHRAL SPHINCTER DYSFUNCTION SYNDROME	0.125	12.5
HEREDITARY ACROKERATOTIC POIKILODERMA	0.125	12.5
45,X/46,XY MIXED GONADAL DYSGENESIS	0.11782240999999999	11.782240999999999
NON-DISTAL MONOSOMY 20Q	0.11658861000000001	11.658861000000002
ELSAHY-WATERS SYNDROME; ESWS	0.11165655399999999	11.165655399999999
BRANCHIOSKELETOGENITAL SYNDROME	0.11111099999999999	11.111099999999999
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.11111099999999999	11.111099999999999
3MC SYNDROME 3	0.11111099999999999	11.111099999999999
46,XX SEX REVERSAL 4; SRXX4	0.11111099999999999	11.111099999999999
SPONDYLOCOSTAL DYSOSTOSIS-HYPOSPADIAS-INTELLECTUAL DISABILITY SYNDROME	0.11111099999999999	11.111099999999999
46,XY SEX REVERSAL 3	0.11111099999999999	11.111099999999999
22Q11.2 MICRODUPLICATION SYNDROME	0.10758780400000001	10.758780400000001
TRISOMY 13	0.10740741000000001	10.740741000000002
TRISOMY 8Q	0.10054555400000001	10.054555400000002
DYSKERATOSIS CONGENITA	0.10054555400000001	10.054555400000002
LAURENCE-MOON SYNDROME	0.1	10.0
CONGENITAL SHORT BOWEL SYNDROME	0.1	10.0
SHORT RIB-POLYDACTYLY SYNDROME	0.1	10.0
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.1	10.0
WAGR SYNDROME	0.1	10.0
46,XX DISORDER OF SEX DEVELOPMENT-ANORECTAL ANOMALIES SYNDROME	0.1	10.0
BLACKFAN-DIAMOND ANEMIA	0.09882350000000001	9.88235
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.09882350000000001	9.88235
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08569503	8.569503000000001
TUBEROUS SCLEROSIS COMPLEX	0.08396535000000001	8.396535
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08269672999999998	8.269672999999997
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.08133220999999999	8.133220999999999
TRICHOHEPATOENTERIC SYNDROME 1	0.07995340000000001	7.995340000000001
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.07692310000000001	7.692310000000001
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	7.692310000000001
BECKWITH-WIEDEMANN SYNDROME	0.07692310000000001	7.692310000000001
TRISOMY 8P	0.07692310000000001	7.692310000000001
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	7.692310000000001
ETHYLMALONIC ENCEPHALOPATHY	0.07692310000000001	7.692310000000001
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.07692310000000001	7.692310000000001
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07692310000000001	7.692310000000001
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	7.692310000000001
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	7.692310000000001
DDOST-CDG	0.07692310000000001	7.692310000000001
PITT-HOPKINS-LIKE SYNDROME	0.07327316	7.327316000000001
TURNER SYNDROME	0.0666667	6.66667
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.0666667	6.66667
MOSAIC MONOSOMY X	0.0666667	6.66667
MONOSOMY X	0.0666667	6.66667
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.06661800999999999	6.661800999999999
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.066411304	6.641130400000001
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.06623091	6.6230910000000005
CHROMOSOME 1P36 DELETION SYNDROME	0.062399354	6.239935399999999
47,XYY SYNDROME	0.0618538	6.18538
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.059369054	5.9369054
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.059369054	5.9369054
ALG11-CDG	0.059369054	5.9369054
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.059369054	5.9369054
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.059369054	5.9369054
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.059369054	5.9369054
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.059369054	5.9369054
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.0588235	5.88235
6P22 MICRODELETION SYNDROME	0.0588235	5.88235
MUCKLE-WELLS SYNDROME	0.0588235	5.88235
ALG12-CDG	0.0588235	5.88235
AFRICAN IRON OVERLOAD	0.0588235	5.88235
INIENCEPHALY	0.0588235	5.88235
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.0588235	5.88235
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.0588235	5.88235
JUNG SYNDROME	0.0588235	5.88235
CAT-EYE SYNDROME	0.0588235	5.88235
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.0588235	5.88235
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.0588235	5.88235
YOUNG-ONSET PARKINSON DISEASE	0.0588235	5.88235
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.0588235	5.88235
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.0588235	5.88235
CHILDHOOD DISINTEGRATIVE DISORDER	0.0588235	5.88235
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.0588235	5.88235
AMISH INFANTILE EPILEPSY SYNDROME	0.053258200000000006	5.32582
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.05210440999999999	5.210440999999999
HISTIDINEMIA	0.05043863	5.043863
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.04907410999999999	4.907410999999999
AICARDI SYNDROME	0.04907410999999999	4.907410999999999
PELIZAEUS-MERZBACHER DISEASE	0.048771930000000005	4.877193
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.048378109999999995	4.837810999999999
XQ12-Q13.3 DUPLICATION SYNDROME	0.048378109999999995	4.837810999999999
49,XXXYY SYNDROME	0.048378109999999995	4.837810999999999
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.04637692	4.637692
300270 ADRENOMYODYSTROPHY	0.04498996399999999	4.498996399999999
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.044696999999999994	4.4697
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.04448623	4.448623
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04312171000000001	4.312171000000001
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.04312171000000001	4.312171000000001
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	4.312171000000001
LISSENCEPHALY, X-LINKED, 2	0.04312171000000001	4.312171000000001
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.042756550000000004	4.275655
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.041666699999999994	4.166669999999999
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	4.166669999999999
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.041666699999999994	4.166669999999999
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.041666699999999994	4.166669999999999
49,XYYYY SYNDROME	0.041666699999999994	4.166669999999999
XP22.13P22.2 DUPLICATION SYNDROME	0.041666699999999994	4.166669999999999
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	4.166669999999999
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.041666699999999994	4.166669999999999
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	4.166669999999999
HAMAMY SYNDROME; HMMS	0.041666699999999994	4.166669999999999
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	4.166669999999999
PGM3-CDG	0.041666699999999994	4.166669999999999
TRISOMY 12P	0.040545554	4.0545554
SMITH-MAGENIS SYNDROME; SMS	0.040545554	4.0545554
KOOLEN-DE VRIES SYNDROME; KDVS	0.040545554	4.0545554
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04	4.0
KAPUR-TORIELLO SYNDROME	0.04	4.0
NON-DISTAL TRISOMY 10Q	0.04	4.0
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.04	4.0
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.04	4.0
ALKAPTONURIA	0.04	4.0
COCAINE EMBRYOFETOPATHY	0.04	4.0
MECKEL SYNDROME, TYPE 5	0.04	4.0
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.04	4.0
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.04	4.0
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.04	4.0
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.04	4.0
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.04	4.0
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.04	4.0
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.04	4.0
3Q13 MICRODELETION SYNDROME	0.04	4.0
ZELLWEGER SYNDROME	0.038744600000000004	3.8744600000000005
SCHINZEL-GIEDION SYNDROME	0.038744600000000004	3.8744600000000005
GENITOURINARY TRACT ANOMALIES	0.037037	3.7037
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	3.7037
HYPERLYSINEMIA, TYPE I	0.037037	3.7037
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.037037	3.7037
ADENOMYOSIS	0.037037	3.7037
FRYNS MICROPHTHALMIA SYNDROME	0.037037	3.7037
NATHALIE SYNDROME	0.037037	3.7037
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	3.7037
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	3.7037
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	3.7037
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	3.7037
SCIMITAR SYNDROME	0.037037	3.7037
DK PHOCOMELIA SYNDROME	0.037037	3.7037
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	3.7037
GALACTORRHEA	0.037037	3.7037
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	3.7037
VISCERAL STEATOSIS, CONGENITAL	0.037037	3.7037
URINARY BLADDER, ATONY OF	0.037037	3.7037
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	3.7037
TESTICULAR TORSION	0.037037	3.7037
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	3.7037
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	3.7037
PEYRONIE DISEASE	0.037037	3.7037
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.036259854	3.6259854000000002
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.036259854	3.6259854000000002
YOU-HOOVER-FONG SYNDROME; YHFS	0.036259854	3.6259854000000002
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036259854	3.6259854000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.036259854	3.6259854000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.035833953999999994	3.5833953999999992
SLC39A8-CDG	0.035714300000000004	3.5714300000000003
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.035714300000000004	3.5714300000000003
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.035714300000000004	3.5714300000000003
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.035714300000000004	3.5714300000000003
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.035714300000000004	3.5714300000000003
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	3.5714300000000003
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.035714300000000004	3.5714300000000003
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.035714300000000004	3.5714300000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.035714300000000004	3.5714300000000003
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.035714300000000004	3.5714300000000003
MICROHYDRANENCEPHALY; MHAC	0.035714300000000004	3.5714300000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.035714300000000004	3.5714300000000003
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.035714300000000004	3.5714300000000003
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.035714300000000004	3.5714300000000003
SECKEL SYNDROME 2; SCKL2	0.0352884	3.5288399999999998
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	3.2803653999999995
ADENYLOSUCCINASE DEFICIENCY	0.032539114	3.2539114000000002
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	3.2258099999999996
DENT DISEASE	0.0322581	3.2258099999999996
DEND SYNDROME	0.0322581	3.2258099999999996
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	3.2258099999999996
SECKEL SYNDROME	0.0322581	3.2258099999999996
9P13 MICRODELETION SYNDROME	0.0322581	3.2258099999999996
OCULODENTODIGITAL DYSPLASIA	0.0322581	3.2258099999999996
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	3.2258099999999996
COG1-CDG	0.0322581	3.2258099999999996
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	3.2258099999999996
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	3.2258099999999996
CONGENITAL ANALBUMINEMIA	0.0322581	3.2258099999999996
MILD CANAVAN DISEASE	0.0322581	3.2258099999999996
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	3.2258099999999996
ISOTRETINOIN-LIKE SYNDROME	0.0322581	3.2258099999999996
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	3.2258099999999996
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	3.2258099999999996
DYSTONIA, JUVENILE-ONSET	0.0322581	3.2258099999999996
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0322581	3.2258099999999996
MEIER-GORLIN SYNDROME 5; MGORS5	0.0322581	3.2258099999999996
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0322581	3.2258099999999996
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.031993560000000004	3.1993560000000003
POTOCKI-LUPSKI SYNDROME	0.025131704	2.5131704
PHELAN-MCDERMID SYNDROME	0.025131704	2.5131704
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.02495131	2.495131
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.02495131	2.495131
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.02495131	2.495131
ALG13-CDG	0.02458615	2.458615
FRAGILE X MENTAL RETARDATION SYNDROME	0.02458615	2.458615
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0202717	2.02717
MYHRE SYNDROME	0.019390034	1.9390034
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.018089454	1.8089454
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.018089454	1.8089454
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.018089454	1.8089454
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.018089454	1.8089454
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.018089454	1.8089454
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.018089454	1.8089454
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.018089454	1.8089454
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.018089454	1.8089454
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.018089454	1.8089454
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.018089454	1.8089454
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.018089454	1.8089454
2Q23.1 MICRODUPLICATION SYNDROME	0.018089454	1.8089454
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.018089454	1.8089454
SALT-AND-PEPPER SYNDROME	0.018089454	1.8089454
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.018089454	1.8089454
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.018089454	1.8089454
ISOLATED COMPLEX I DEFICIENCY	0.018089454	1.8089454
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.018089454	1.8089454
MENTAL RETARDATION, X-LINKED 98; MRX98	0.018089454	1.8089454
MENTAL RETARDATION, X-LINKED 104; MRX104	0.018089454	1.8089454
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.018089454	1.8089454
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.018089454	1.8089454
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.018089454	1.8089454
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.018089454	1.8089454
8Q24.3 MICRODELETION SYNDROME	0.018089454	1.8089454
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.018089454	1.8089454
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.018089454	1.8089454
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.018089454	1.8089454
HEART AND BRAIN MALFORMATION SYNDROME	0.018089454	1.8089454
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.018089454	1.8089454
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.018089454	1.8089454
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.018089454	1.8089454
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.018089454	1.8089454
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.018089454	1.8089454
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.018089454	1.8089454
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0175439	1.7543900000000001
RETT SYNDROME, CONGENITAL VARIANT	0.0175439	1.7543900000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0175439	1.7543900000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0175439	1.7543900000000001
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0175439	1.7543900000000001
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0175439	1.7543900000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0175439	1.7543900000000001
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	1.72414
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.72414
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.72414
RHEUMATOID ARTHRITIS	0.0172414	1.72414
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.72414
JUMPING FRENCHMAN OF MAINE	0.0172414	1.72414
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	1.72414
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	1.72414
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	1.72414
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	1.72414
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.72414
MOTION SICKNESS	0.0172414	1.72414
PALMOMENTAL REFLEX	0.0172414	1.72414
ENDOCARDIAL FIBROELASTOSIS	0.0172414	1.72414
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.72414
MOSAIC TRISOMY 15	0.0172414	1.72414
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	1.72414
DIASTEMATOMYELIA	0.0172414	1.72414
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.72414
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	1.72414
ERYTHERMALGIA, PRIMARY	0.0172414	1.72414
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.72414
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.72414
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.72414
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.72414
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.72414
CERVICAL RIB	0.0172414	1.72414
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.72414
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.72414
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	1.72414
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	1.72414
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.72414
THUMBS, CONGENITAL CLASPED	0.0172414	1.72414
TRANSSEXUALITY	0.0172414	1.72414
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.72414
MYOPATHY, CONGENITAL	0.0172414	1.72414
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.72414
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.72414
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	1.72414
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.72414
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.72414
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.72414
CARDIAC ARRHYTHMIA	0.0172414	1.72414
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.72414
SICKLE CELL ANEMIA	0.0172414	1.72414
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.72414
ALCOHOL DEPENDENCE	0.0172414	1.72414
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.72414
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	1.72414
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	1.72414
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	1.72414
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.72414
269800 SENILE PLAQUE FORMATION	0.0172414	1.72414
1Q41Q42 MICRODELETION SYNDROME	0.01617934	1.617934
RAYNAUD-CLAES SYNDROME; MRXSRC	0.016028894000000002	1.6028894000000002
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.01444966	1.444966
8P INVERTED DUPLICATION/DELETION SYNDROME	0.01444966	1.444966
CHRISTIANSON SYNDROME	0.01444966	1.444966
GABRIELE-DE VRIES SYNDROME	0.01444966	1.444966
4Q21 MICRODELETION SYNDROME	0.01444966	1.444966
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01444966	1.444966
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.01444966	1.444966
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.01411882	1.411882
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.01411882	1.411882
2Q24 MICRODELETION SYNDROME	0.01411882	1.411882
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01411882	1.411882
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.01411882	1.411882
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.012347784	1.2347784000000002
TONNE-KALSCHEUER SYNDROME; TOKAS	0.012347784	1.2347784000000002
SOTOS SYNDROME	0.012347784	1.2347784000000002
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.012347784	1.2347784000000002
CORNELIA DE LANGE SYNDROME 1	0.01180223	1.180223
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.01180223	1.180223
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.010983264	1.0983264
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.010618104	1.0618104
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.010618104	1.0618104
3Q29 MICRODELETION SYNDROME	0.010618104	1.0618104
22Q11.2 DELETION SYNDROME	0.010618104	1.0618104
1Q21.1 MICRODUPLICATION SYNDROME	0.010618104	1.0618104
SMITH-LEMLI-OPITZ SYNDROME	0.010618104	1.0618104
1P36 DELETION SYNDROME	0.010618104	1.0618104
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.010618104	1.0618104
WITTEVEEN-KOLK SYNDROME	0.010618104	1.0618104
LOWRY-MACLEAN SYNDROME	0.01043771	1.043771
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.01043771	1.043771
INTELLECTUAL DISABILITY, WOLFF TYPE	0.01043771	1.043771
RING CHROMOSOME 7 SYNDROME	0.01043771	1.043771
YUNIS-VARON SYNDROME	0.01043771	1.043771
TRISOMY XQ28	0.01043771	1.043771
FRYNS SYNDROME	0.01043771	1.043771
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.01043771	1.043771
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.01043771	1.043771
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.010287264	1.0287264
COFFIN-SIRIS SYNDROME 1; CSS1	0.010287264	1.0287264
KLEEFSTRA SYNDROME	0.010287264	1.0287264
DISTAL MONOSOMY 15Q	0.010287264	1.0287264
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.010287264	1.0287264
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.010287264	1.0287264
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.010287264	1.0287264
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.010287264	1.0287264
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.010287264	1.0287264
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.01007255	1.007255
RING CHROMOSOME 13 SYNDROME	0.01007255	1.007255
KLEEFSTRA SYNDROME	0.01007255	1.007255
CORNELIA DE LANGE SYNDROME	0.01007255	1.007255
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.01007255	1.007255
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.01007255	1.007255
CRI-DU-CHAT SYNDROME	0.01007255	1.007255
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00974171	0.9741710000000001
20Q13.33 MICRODELETION SYNDROME	0.00974171	0.9741710000000001
SILVER-RUSSELL SYNDROME	0.00974171	0.9741710000000001
MICROPHTHALMIA, SYNDROMIC 1	0.00974171	0.9741710000000001
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00974171	0.9741710000000001
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.009317484000000001	0.9317484
WHITE-SUTTON SYNDROME; WHSUS	0.009317484000000001	0.9317484
MENTAL RETARDATION, X-LINKED 90	0.009317484000000001	0.9317484
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.009317484000000001	0.9317484
MONOSOMY 18P	0.009317484000000001	0.9317484
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.009317484000000001	0.9317484
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.009317484000000001	0.9317484
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.9317484
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.009317484000000001	0.9317484
LANDAU-KLEFFNER SYNDROME	0.009317484000000001	0.9317484
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.9317484
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.009317484000000001	0.9317484
INFANTILE REFSUM DISEASE	0.009317484000000001	0.9317484
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	0.9317484
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.009317484000000001	0.9317484
WEAVER SYNDROME	0.009317484000000001	0.9317484
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009317484000000001	0.9317484
ARGININEMIA	0.009317484000000001	0.9317484
20Q11.2 MICRODELETION SYNDROME	0.009317484000000001	0.9317484
FETAL ALCOHOL SYNDROME	0.009317484000000001	0.9317484
HEREDITARY FOLATE MALABSORPTION	0.009317484000000001	0.9317484
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.009317484000000001	0.9317484
LOCKED-IN SYNDROME	0.00877193	0.8771930000000001
PFAPA SYNDROME	0.00877193	0.8771930000000001
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.8771930000000001
CAFFEY DISEASE	0.00877193	0.8771930000000001
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.8771930000000001
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.8771930000000001
BREATH-HOLDING SPELLS	0.00877193	0.8771930000000001
HISTIDINEMIA	0.00877193	0.8771930000000001
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.8771930000000001
NANCE-HORAN SYNDROME	0.00877193	0.8771930000000001
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.8771930000000001
ANGELMAN SYNDROME	0.00877193	0.8771930000000001
CORTICOBASAL SYNDROME	0.00877193	0.8771930000000001
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.8771930000000001
PINEOBLASTOMA	0.00877193	0.8771930000000001
ISOLATED CEREBELLAR AGENESIS	0.00877193	0.8771930000000001
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.8771930000000001
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.8771930000000001
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.8771930000000001
FAMILIAL DYSAUTONOMIA	0.00877193	0.8771930000000001
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00877193	0.8771930000000001
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.8771930000000001
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00877193	0.8771930000000001
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00877193	0.8771930000000001
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.8771930000000001
MENKES DISEASE	0.00877193	0.8771930000000001
NEUROFERRITINOPATHY	0.00877193	0.8771930000000001
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	0.8771930000000001
CRYPTOCOCCOSIS	0.00877193	0.8771930000000001
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00877193	0.8771930000000001
LESCH-NYHAN SYNDROME	0.00877193	0.8771930000000001
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00877193	0.8771930000000001
NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.8771930000000001
DIENCEPHALIC SYNDROME	0.00877193	0.8771930000000001
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.8771930000000001
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00877193	0.8771930000000001
SCLERODERMA	0.00877193	0.8771930000000001
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.00877193	0.8771930000000001
SNEDDON SYNDROME	0.00877193	0.8771930000000001
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.8771930000000001
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.8771930000000001
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.8771930000000001
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.8771930000000001
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.8771930000000001
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00877193	0.8771930000000001
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.8771930000000001
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.8771930000000001
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.8771930000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	0.8771930000000001
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.8771930000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.8771930000000001
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.8771930000000001
MILROY DISEASE	0.00877193	0.8771930000000001
KEIPERT SYNDROME	0.00877193	0.8771930000000001
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.8771930000000001
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.8771930000000001
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.8771930000000001
2Q33.1 DELETION SYNDROME	0.00877193	0.8771930000000001
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00877193	0.8771930000000001
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.00877193	0.8771930000000001
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.8771930000000001
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.8771930000000001
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.00877193	0.8771930000000001
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.8771930000000001
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.8771930000000001
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.8771930000000001
RHEUMATIC FEVER	0.00877193	0.8771930000000001
HUNTINGTON DISEASE	0.00877193	0.8771930000000001
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.8771930000000001
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.8771930000000001
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.007952964	0.7952964
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.7952964
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.7952964
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.7952964
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.007952964	0.7952964
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.007952964	0.7952964
PIERPONT SYNDROME	0.007952964	0.7952964
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.007952964	0.7952964
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.007952964	0.7952964
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.7952964
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.007952964	0.7952964
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.007587804	0.7587804
CLASSIC PHENYLKETONURIA	0.007587804	0.7587804
XQ28 (MECP2) DUPLICATION	0.007587804	0.7587804
2Q37 MICRODELETION SYNDROME	0.007587804	0.7587804
48,XXYY SYNDROME	0.007587804	0.7587804
AUSTRALIA ANTIGEN	0.007587804	0.7587804
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.007587804	0.7587804
15Q13.3 MICRODELETION SYNDROME	0.007587804	0.7587804
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.007587804	0.7587804
17P11.2 MICRODUPLICATION SYNDROME	0.007587804	0.7587804
CHARGE SYNDROME	0.007587804	0.7587804
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.007587804	0.7587804
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.007587804	0.7587804
PRADER-WILLI SYNDROME; PWS	0.007587804	0.7587804
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.007587804	0.7587804
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.007587804	0.7587804
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.007587804	0.7587804
49,XXXXY SYNDROME	0.007587804	0.7587804
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.007587804	0.7587804
6Q16 MICRODELETION SYNDROME	0.007587804	0.7587804
48,XXXY SYNDROME	0.007587804	0.7587804
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.007587804	0.7587804
MAN1B1-CDG	0.007587804	0.7587804
2P15P16.1 MICRODELETION SYNDROME	0.007587804	0.7587804
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.007587804	0.7587804
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.007587804	0.7587804
15Q11Q13 MICRODUPLICATION SYNDROME	0.007587804	0.7587804
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.007587804	0.7587804
10Q22.3Q23.3 MICRODELETION SYNDROME	0.007587804	0.7587804
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.007587804	0.7587804
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.007587804	0.7587804
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.007587804	0.7587804
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.007587804	0.7587804
17Q12 MICRODELETION SYNDROME	0.007587804	0.7587804
16P13.11 MICRODUPLICATION SYNDROME	0.007587804	0.7587804
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.007587804	0.7587804
15Q14 MICRODELETION SYNDROME	0.007587804	0.7587804
1Q21.1 MICRODELETION SYNDROME	0.007587804	0.7587804
TIMOTHY SYNDROME; TS	0.007587804	0.7587804
2Q32Q33 MICRODELETION SYNDROME	0.007587804	0.7587804
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.007587804	0.7587804
MENTAL RETARDATION, X-LINKED 9	0.007587804	0.7587804
MENTAL RETARDATION, X-LINKED 88	0.007587804	0.7587804
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.007587804	0.7587804
17Q21.31 MICRODUPLICATION SYNDROME	0.007587804	0.7587804
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.007587804	0.7587804
MACROCEPHALY/AUTISM SYNDROME	0.007587804	0.7587804
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.007587804	0.7587804
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00740741	0.740741
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00740741	0.740741
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00740741	0.740741
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00740741	0.740741
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.740741
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.00740741	0.740741
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00740741	0.740741
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.740741
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00740741	0.740741
AMISH LETHAL MICROCEPHALY	0.00740741	0.740741
TEMPLE-BARAITSER SYNDROME	0.00740741	0.740741
CONO-SPONDYLAR DYSPLASIA	0.00740741	0.740741
SECKEL SYNDROME 7; SCKL7	0.00740741	0.740741
BOWEN-CONRADI SYNDROME	0.00740741	0.740741
HEREDITARY METHEMOGLOBINEMIA	0.00740741	0.740741
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00740741	0.740741
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00740741	0.740741
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.740741
MUCOLIPIDOSIS TYPE II	0.00740741	0.740741
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.740741
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00740741	0.740741
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.740741
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.740741
HALL-RIGGS SYNDROME	0.00740741	0.740741
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00740741	0.740741
ADRENOMYODYSTROPHY	0.00740741	0.740741
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.740741
COG8-CDG	0.00740741	0.740741
QAZI-MARKOUIZOS SYNDROME	0.00740741	0.740741
SMITH-FINEMAN-MYERS SYNDROME	0.00740741	0.740741
MONOSOMY 5P	0.00740741	0.740741
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00740741	0.740741
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00740741	0.740741
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.00740741	0.740741
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.740741
MEHMO SYNDROME	0.00740741	0.740741
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00740741	0.740741
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00740741	0.740741
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.740741
CROME SYNDROME	0.00740741	0.740741
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00740741	0.740741
WARBURG MICRO SYNDROME 2; WARBM2	0.00740741	0.740741
LISSENCEPHALY 5; LIS5	0.00740741	0.740741
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00740741	0.740741
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00740741	0.740741
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00740741	0.740741
UNILATERAL POLYMICROGYRIA	0.00740741	0.740741
DPM1-CDG	0.00740741	0.740741
KEPPEN-LUBINSKY SYNDROME	0.00740741	0.740741
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.740741
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.740741
COFFIN-LOWRY SYNDROME	0.00740741	0.740741
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.740741
KID SYNDROME	0.00740741	0.740741
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.740741
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00740741	0.740741
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.740741
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00740741	0.740741
ADENYLOSUCCINATE LYASE DEFICIENCY	0.00740741	0.740741
DISTAL MONOSOMY 10P	0.00740741	0.740741
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.00740741	0.740741
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.00740741	0.740741
NEONATAL ADRENOLEUKODYSTROPHY	0.00740741	0.740741
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00740741	0.740741
CRANIOFACIAL DYSSYNOSTOSIS	0.00740741	0.740741
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00740741	0.740741
COFS SYNDROME	0.00740741	0.740741
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00740741	0.740741
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.00740741	0.740741
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00740741	0.740741
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00740741	0.740741
HENNEKAM-BEEMER SYNDROME	0.00740741	0.740741
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.00740741	0.740741
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00740741	0.740741
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00740741	0.740741
KLEEFSTRA SYNDROME 2; KLEFS2	0.007256964	0.7256964
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.007256964	0.7256964
OBESITY DUE TO SIM1 DEFICIENCY	0.007256964	0.7256964
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.007256964	0.7256964
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.007256964	0.7256964
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007256964	0.7256964
FRIED SYNDROME	0.007256964	0.7256964
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.007256964	0.7256964
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.007256964	0.7256964
HYPERPROLINEMIA, TYPE I	0.007256964	0.7256964
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.007256964	0.7256964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.007256964	0.7256964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.007256964	0.7256964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.007256964	0.7256964
16P13.2 MICRODELETION SYNDROME	0.007256964	0.7256964
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.007256964	0.7256964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.007256964	0.7256964
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.007256964	0.7256964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.007256964	0.7256964
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.007256964	0.7256964
SHUKLA-VERNON SYNDROME; SHUVER	0.007256964	0.7256964
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.007256964	0.7256964
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.007256964	0.7256964
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.007256964	0.7256964
TETRASOMY 9P	0.007256964	0.7256964
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.007256964	0.7256964
HELSMOORTEL-VAN DER AA SYNDROME	0.007256964	0.7256964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.007256964	0.7256964
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.007256964	0.7256964
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.007256964	0.7256964
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.007256964	0.7256964
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.007256964	0.7256964
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.007256964	0.7256964
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.007256964	0.7256964
1P21.3 MICRODELETION SYNDROME	0.007256964	0.7256964
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.007256964	0.7256964
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.007256964	0.7256964
LUSCAN-LUMISH SYNDROME; LLS	0.007256964	0.7256964
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.007256964	0.7256964
CHROMOSOME 16P13.2 DELETION SYNDROME	0.007256964	0.7256964
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007256964	0.7256964
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.007256964	0.7256964
PITT-HOPKINS SYNDROME	0.007256964	0.7256964
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.007256964	0.7256964
MONOSOMY 22Q13.3	0.007256964	0.7256964
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.007256964	0.7256964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.007256964	0.7256964
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.007256964	0.7256964
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.007256964	0.7256964
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.007256964	0.7256964
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007256964	0.7256964
PRADER-WILLI-LIKE SYNDROME	0.007256964	0.7256964
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.007256964	0.7256964
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.007256964	0.7256964
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.007256964	0.7256964
OGDEN SYNDROME	0.007256964	0.7256964
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.007256964	0.7256964
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.007256964	0.7256964
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.007256964	0.7256964
MYOCLONIC-ASTASTIC EPILEPSY	0.007256964	0.7256964
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007256964	0.7256964
DISTAL 16P11.2 MICRODELETION SYNDROME	0.007256964	0.7256964
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.007256964	0.7256964
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007256964	0.7256964
XQ25 MICRODUPLICATION SYNDROME	0.007256964	0.7256964
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.007256964	0.7256964
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.007256964	0.7256964
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.007256964	0.7256964
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.007256964	0.7256964
RING CHROMOSOME 22 SYNDROME	0.007256964	0.7256964
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.007256964	0.7256964
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.007256964	0.7256964
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.007256964	0.7256964
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.007256964	0.7256964
TURNPENNY-FRY SYNDROME; TPFS	0.007256964	0.7256964
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.007256964	0.7256964
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.007256964	0.7256964
HSD10 DISEASE	0.007256964	0.7256964
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.007256964	0.7256964
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.007256964	0.7256964
DOORS SYNDROME	0.007256964	0.7256964
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.007256964	0.7256964
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.007256964	0.7256964
CHIME SYNDROME	0.00704225	0.704225
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00704225	0.704225
NORRIE DISEASE	0.00704225	0.704225
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00704225	0.704225
GOLDENHAR SYNDROME	0.00704225	0.704225
LEUKOCYTE ADHESION DEFICIENCY	0.00704225	0.704225
MOMO SYNDROME	0.00704225	0.704225
CHROMOSOME 17Q12 DELETION SYNDROME	0.00704225	0.704225
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00704225	0.704225
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00704225	0.704225
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00704225	0.704225
MOEBIUS SYNDROME	0.00704225	0.704225
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00704225	0.704225
AUTISM, SUSCEPTIBILITY TO, 18	0.00704225	0.704225
RECESSIVE X-LINKED ICHTHYOSIS	0.00704225	0.704225
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.00704225	0.704225
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00704225	0.704225
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00704225	0.704225
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00704225	0.704225
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00704225	0.704225
TUBEROUS SCLEROSIS-1	0.00704225	0.704225
NANCE-HORAN SYNDROME	0.00704225	0.704225
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00704225	0.704225
WILLIAMS SYNDROME	0.00704225	0.704225
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00704225	0.704225
TUBEROUS SCLEROSIS 2; TSC2	0.00704225	0.704225
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00704225	0.704225
FRAGILE X SYNDROME	0.00704225	0.704225
HYPERLEXIA	0.00704225	0.704225
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00704225	0.704225
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.00704225	0.704225
MELAS	0.00704225	0.704225
CYCLIC VOMITING SYNDROME	0.00704225	0.704225
PRIMROSE SYNDROME; PRIMS	0.00704225	0.704225
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00704225	0.704225
RETT SYNDROME	0.00704225	0.704225
16Q24.3 MICRODELETION SYNDROME	0.00704225	0.704225
BRUNNER SYNDROME; BRNRS	0.00704225	0.704225
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00704225	0.704225
MENTAL RETARDATION, X-LINKED 21	0.00704225	0.704225
STURGE-WEBER SYNDROME	0.00671141	0.671141
3P25.3 MICRODELETION SYNDROME	0.00671141	0.671141
DUPLICATION/INVERSION 15Q11	0.00671141	0.671141
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00671141	0.671141
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00671141	0.671141
9Q21.13 MICRODELETION SYNDROME	0.00671141	0.671141
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00671141	0.671141
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00671141	0.671141
PRADER-WILLI SYNDROME	0.00671141	0.671141
FRAXE INTELLECTUAL DISABILITY	0.00671141	0.671141
WOLFRAM-LIKE SYNDROME	0.00671141	0.671141
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00671141	0.671141
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.00671141	0.671141
COG5-CDG	0.00671141	0.671141
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.00671141	0.671141
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00671141	0.671141
LENNOX-GASTAUT SYNDROME	0.00671141	0.671141
DRAVET SYNDROME	0.00671141	0.671141
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00671141	0.671141
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.00671141	0.671141
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00671141	0.671141
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00671141	0.671141
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.00671141	0.671141
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00671141	0.671141
5Q14.3 MICRODELETION SYNDROME	0.00671141	0.671141
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00671141	0.671141
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.00671141	0.671141
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00671141	0.671141
46,XY SEX REVERSAL 9; SRXY9	0.00671141	0.671141
PTEN HAMARTOMA TUMOR SYNDROME	0.00671141	0.671141
CHILDHOOD APRAXIA OF SPEECH	0.00671141	0.671141
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00671141	0.671141
RETT SYNDROME; RTT	0.00671141	0.671141
MENTAL RETARDATION, X-LINKED 82	0.00671141	0.671141
HYPERTELORISM, TEEBI TYPE; TBHS	0.00671141	0.671141
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.003575854	0.3575854
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.003575854	0.3575854
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.003575854	0.3575854
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.003575854	0.3575854
MENTAL RETARDATION, X-LINKED 106; MRX106	0.003575854	0.3575854
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.003575854	0.3575854
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.003575854	0.3575854
VASCULAR EHLERS-DANLOS SYNDROME	0.003575854	0.3575854
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.003575854	0.3575854
CEREBROFACIOARTICULAR SYNDROME	0.003575854	0.3575854
%300712 CRANIOFACIOSKELETAL SYNDROME	0.003575854	0.3575854
SILVER-RUSSELL SYNDROME; SRS	0.003575854	0.3575854
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.003575854	0.3575854
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.003575854	0.3575854
CRANIOFRONTONASAL SYNDROME; CFNS	0.003575854	0.3575854
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.003575854	0.3575854
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.003575854	0.3575854
CHROMOSOME 9P DELETION SYNDROME	0.003575854	0.3575854
WOLF-HIRSCHHORN SYNDROME	0.003575854	0.3575854
OTOPALATODIGITAL SYNDROME TYPE 2	0.003575854	0.3575854
DISTAL MONOSOMY 9P	0.003575854	0.3575854
HARTSFIELD SYNDROME; HRTFDS	0.003575854	0.3575854
MOSAIC TRISOMY 14	0.003575854	0.3575854
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.003575854	0.3575854
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.003575854	0.3575854
OPITZ G/BBB SYNDROME	0.003575854	0.3575854
FG SYNDROME TYPE 1	0.003575854	0.3575854
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.003575854	0.3575854
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.003575854	0.3575854
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.003575854	0.3575854
15Q24 MICRODELETION SYNDROME	0.003575854	0.3575854
YUNIS-VARON SYNDROME	0.003575854	0.3575854
3C SYNDROME	0.003575854	0.3575854
PALLISTER-HALL SYNDROME	0.003575854	0.3575854
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.003575854	0.3575854
6Q TERMINAL DELETION SYNDROME	0.003575854	0.3575854
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.003575854	0.3575854
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.003575854	0.3575854
RITSCHER-SCHINZEL SYNDROME 1	0.003575854	0.3575854
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.003575854	0.3575854
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.003575854	0.3575854
MIRAGE SYNDROME; MIRAGE	0.003575854	0.3575854
MEIER-GORLIN SYNDROME 7	0.003575854	0.3575854
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.003575854	0.3575854
MICROPHTHALMIA, SYNDROMIC 3	0.003575854	0.3575854
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.003575854	0.3575854
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.003575854	0.3575854
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.003575854	0.3575854
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.003575854	0.3575854
PETERS-PLUS SYNDROME; PTRPLS	0.003575854	0.3575854
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.003575854	0.3575854
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.003575854	0.3575854
3MC SYNDROME 2	0.003575854	0.3575854
SIMPSON-GOLABI-BEHMEL SYNDROME	0.003575854	0.3575854
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.003575854	0.3575854
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.003575854	0.3575854
BARDET-BIEDL SYNDROME 8; BBS8	0.003575854	0.3575854
FANCONI ANEMIA	0.003575854	0.3575854
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.003575854	0.3575854
DIAMOND-BLACKFAN ANEMIA 5	0.003575854	0.3575854
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.003575854	0.3575854
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.003575854	0.3575854
PETERS PLUS SYNDROME	0.003575854	0.3575854
19P13.12 MICRODELETION SYNDROME	0.003575854	0.3575854
PHENOBARBITAL EMBRYOPATHY	0.003575854	0.3575854
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.003575854	0.3575854
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.003575854	0.3575854
N SYNDROME	0.003575854	0.3575854
MONOSOMY 9P	0.003575854	0.3575854
CDAGS SYNDROME	0.003575854	0.3575854
MARDEN-WALKER SYNDROME	0.003575854	0.3575854
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.003575854	0.3575854
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.003575854	0.3575854
8P23.1 MICRODELETION SYNDROME	0.003575854	0.3575854
TOWNES-BROCKS SYNDROME 1; TBS1	0.003575854	0.3575854
CREE MENTAL RETARDATION SYNDROME	0.003575854	0.3575854
KOOLEN-DE VRIES SYNDROME	0.003575854	0.3575854
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.003575854	0.3575854
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.003575854	0.3575854
EAR-PATELLA-SHORT STATURE SYNDROME	0.003575854	0.3575854
BRAIN-LUNG-THYROID SYNDROME	0.003575854	0.3575854
FETAL TRIMETHADIONE SYNDROME	0.003575854	0.3575854
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.003575854	0.3575854
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.003575854	0.3575854
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.003575854	0.3575854
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0030303	0.30303
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.0030303	0.30303
MARDEN-WALKER SYNDROME	0.0030303	0.30303
TOWNES-BROCKS SYNDROME 2; TBS2	0.0030303	0.30303
LAMBERT SYNDROME	0.0030303	0.30303
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0030303	0.30303
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.0030303	0.30303
OTOONYCHOPERONEAL SYNDROME	0.0030303	0.30303
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0030303	0.30303
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.0030303	0.30303
CONGENITAL ADRENAL HYPERPLASIA	0.0030303	0.30303
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0030303	0.30303
MARTINEZ-FRIAS SYNDROME	0.0030303	0.30303
601095 HARROD SYNDROME	0.0030303	0.30303
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0030303	0.30303
DIPHALLIA	0.0030303	0.30303
ROBERTS SYNDROME; RBS	0.0030303	0.30303
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.0030303	0.30303
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0030303	0.30303
RADIAL HYPOPLASIA-TRIPHALANGEAL THUMBS-HYPOSPADIAS-MAXILLARY DIASTEMA SYNDROME	0.0030303	0.30303
46,XY PARTIAL GONADAL DYSGENESIS	0.0030303	0.30303
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.0030303	0.30303
JOHANSON-BLIZZARD SYNDROME; JBS	0.0030303	0.30303
N SYNDROME	0.0030303	0.30303
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.0030303	0.30303
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.0030303	0.30303
HAND-FOOT-GENITAL SYNDROME	0.0030303	0.30303
PALLISTER-KILLIAN SYNDROME	0.0030303	0.30303
CHROMOSOME 18Q DELETION SYNDROME	0.0030303	0.30303
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.0030303	0.30303
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0030303	0.30303
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0030303	0.30303
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.0030303	0.30303
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.0030303	0.30303
MICROPHTHALMIA, LENZ TYPE	0.0030303	0.30303
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0030303	0.30303
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.0030303	0.30303
MEIER-GORLIN SYNDROME 3; MGORS3	0.0030303	0.30303
ISOLATED ANORECTAL MALFORMATION	0.0030303	0.30303
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0030303	0.30303
46,XY SEX REVERSAL 6; SRXY6	0.0030303	0.30303
JOHANSON-BLIZZARD SYNDROME	0.0030303	0.30303
DUBOWITZ SYNDROME	0.0030303	0.30303
DUBOWITZ SYNDROME	0.0030303	0.30303
ELLIS-VAN CREVELD SYNDROME	0.0030303	0.30303
FRYNS SYNDROME; FRNS	0.0030303	0.30303
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.0030303	0.30303
GENITOPALATOCARDIAC SYNDROME	0.0030303	0.30303
KABUKI SYNDROME	0.0030303	0.30303
MOWAT-WILSON SYNDROME; MOWS	0.0030303	0.30303
HYDROLETHALUS SYNDROME 1	0.0030303	0.30303
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.0030303	0.30303
JUBERG-HAYWARD SYNDROME	0.0030303	0.30303
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.0030303	0.30303
HYPOGONADISM, MALEHYPOGONADISM AND TESTICULAR ATROPHY, INCLUDED	0.0030303	0.30303
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.0030303	0.30303
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0030303	0.30303
TRIPLOIDY	0.0030303	0.30303
ACROCALLOSAL SYNDROME	0.0030303	0.30303
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.0030303	0.30303
TRISOMY 20P	0.0030303	0.30303
ELLIS VAN CREVELD SYNDROME	0.0030303	0.30303
GENITOPALATOCARDIAC SYNDROME	0.0030303	0.30303
46,XX SEX REVERSAL 1; SRXX1	0.0030303	0.30303
CRANIOFRONTONASAL DYSPLASIA	0.0030303	0.30303
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.0030303	0.30303
CURRARINO SYNDROME	0.0030303	0.30303
PENOSCROTAL TRANSPOSITION	0.0030303	0.30303
CHARGE-LIKE SYNDROME, X-LINKED	0.0030303	0.30303
FRASER SYNDROME	0.0030303	0.30303
ACROCARDIOFACIAL SYNDROME	0.0030303	0.30303
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.0030303	0.30303
THORACOABDOMINAL SYNDROME	0.0030303	0.30303
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.0030303	0.30303
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.0030303	0.30303
3M SYNDROME	0.0030303	0.30303
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.0030303	0.30303
RESTRICTIVE DERMOPATHY	0.0030303	0.30303
RENPENNING SYNDROME 1; RENS1	0.0030303	0.30303
METHIMAZOLE EMBRYOFETOPATHY	0.0030303	0.30303
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0030303	0.30303
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0030303	0.30303
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.0030303	0.30303
TRISOMY 4P	0.0030303	0.30303
DIETHYLSTILBESTROL SYNDROME	0.0030303	0.30303
EEC SYNDROME	0.0030303	0.30303
ACROFRONTOFACIONASAL DYSOSTOSIS	0.0030303	0.30303
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.0030303	0.30303
BIEMOND SYNDROME TYPE 2	0.0030303	0.30303
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0030303	0.30303
SERKAL SYNDROME	0.0030303	0.30303
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.0030303	0.30303
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.0030303	0.30303
RESTRICTIVE DERMOPATHY, LETHAL	0.0030303	0.30303
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.0030303	0.30303
BARDET-BIEDL SYNDROME 6; BBS6	0.0030303	0.30303
19Q13.11 MICRODELETION SYNDROME	0.0030303	0.30303
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0030303	0.30303
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0030303	0.30303
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.0030303	0.30303
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.0030303	0.30303
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0030303	0.30303
HUNTER-MACDONALD SYNDROME	0.0030303	0.30303
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.0030303	0.30303
RENPENNING SYNDROME	0.0030303	0.30303
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.0030303	0.30303
SPINA BIFIDA-HYPOSPADIAS SYNDROME	0.0030303	0.30303
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.0030303	0.30303
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.0030303	0.30303
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.0030303	0.30303
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.0030303	0.30303
LAMBERT SYNDROME	0.0030303	0.30303
PENTALOGY OF CANTRELL	0.0030303	0.30303
MOWAT-WILSON SYNDROME	0.0030303	0.30303
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.0030303	0.30303
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.0030303	0.30303
46,XX OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.0030303	0.30303
HARROD SYNDROME	0.0030303	0.30303
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.0030303	0.30303
POLAND SYNDROME	0.0030303	0.30303
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0030303	0.30303
AXENFELD-RIEGER SYNDROME	0.0030303	0.30303
RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARYDIASTEMA	0.0030303	0.30303
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.0030303	0.30303
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0030303	0.30303
IMAGE SYNDROME	0.0030303	0.30303
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.0030303	0.30303
DISTAL TRISOMY 5Q	0.0030303	0.30303
LEYDIG CELL HYPOPLASIA	0.0030303	0.30303
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0030303	0.30303
BRANCHIOOCULOFACIAL SYNDROME	0.0030303	0.30303
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0030303	0.30303
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0030303	0.30303
HAND-FOOT-GENITAL SYNDROME; HFG	0.0030303	0.30303
SECKEL SYNDROME 1; SCKL1	0.0030303	0.30303
JACOBSEN SYNDROME	0.0030303	0.30303
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.0030303	0.30303
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.0030303	0.30303
VACTERL/VATER ASSOCIATION	0.0030303	0.30303
FLOATING-HARBOR SYNDROME	0.0030303	0.30303
%146450 HYPOSPADIAS 3, AUTOSOMAL; HYSP3	0.0030303	0.30303
OMODYSPLASIA	0.0030303	0.30303
ACROOSTEOLYSIS DOMINANT TYPE	0.0030303	0.30303
LUMBAR SYNDROME	0.0030303	0.30303
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.0030303	0.30303
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0030303	0.30303
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.0030303	0.30303
MECKEL SYNDROME, TYPE 10; MKS10	0.0030303	0.30303
ANUS, IMPERFORATE	0.0030303	0.30303
TOWNES-BROCKS SYNDROME	0.0030303	0.30303
PARTIAL ANDROGEN INSENSITIVITY SYNDROME	0.0030303	0.30303
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY	0.0030303	0.30303
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.0030303	0.30303
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.0030303	0.30303
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.0030303	0.30303
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.0030303	0.30303
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.0030303	0.30303
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0030303	0.30303
15Q24 RECURRENT MICRODELETION SYNDROME	0.0030303	0.30303
ACROCALLOSAL SYNDROME; ACLS	0.0030303	0.30303
LIPOID CONGENITAL ADRENAL HYPERPLASIA	0.0030303	0.30303
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.0030303	0.30303
TIBIAL HEMIMELIA	0.0030303	0.30303
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.0030303	0.30303
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.0545554
CURRARINO SYNDROME	0.000545554	0.0545554
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.0545554
MEVALONIC ACIDURIA	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.0545554
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.0545554
DPAGT1-CDG	0.000545554	0.0545554
CHAR SYNDROME	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000545554	0.0545554
DE BARSY SYNDROME	0.000545554	0.0545554
CONGENITAL VARICELLA SYNDROME	0.000545554	0.0545554
PELGER-HUET ANOMALY; PHA	0.000545554	0.0545554
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.0545554
SIALIDOSIS TYPE 2	0.000545554	0.0545554
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.0545554
TREACHER-COLLINS SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.0545554
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.000545554	0.0545554
W SYNDROME	0.000545554	0.0545554
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.0545554
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.0545554
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000545554	0.0545554
PETTIGREW SYNDROME	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000545554	0.0545554
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.0545554
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.0545554
AARSKOG-SCOTT SYNDROME	0.000545554	0.0545554
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.0545554
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.0545554
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.0545554
GLYCEROL KINASE DEFICIENCY; GKD	0.000545554	0.0545554
OTOFACIOCERVICAL SYNDROME	0.000545554	0.0545554
WRINKLY SKIN SYNDROME	0.000545554	0.0545554
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.0545554
PEHO SYNDROME	0.000545554	0.0545554
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.0545554
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.0545554
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.0545554
TETRASOMY X	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000545554	0.0545554
XQ25 DUPLICATION SYNDROME	0.000545554	0.0545554
WALKER-WARBURG SYNDROME	0.000545554	0.0545554
PERLMAN SYNDROME	0.000545554	0.0545554
TARP SYNDROME	0.000545554	0.0545554
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.0545554
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000545554	0.0545554
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.0545554
CONGENITAL TOXOPLASMOSIS	0.000545554	0.0545554
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.000545554	0.0545554
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.000545554	0.0545554
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000545554	0.0545554
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.0545554
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.0545554
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.0545554
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000545554	0.0545554
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000545554	0.0545554
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000545554	0.0545554
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.0545554
JOUBERT SYNDROME 10	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.0545554
SIALURIA	0.000545554	0.0545554
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.0545554
BRESEK SYNDROME	0.000545554	0.0545554
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.0545554
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.0545554
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000545554	0.0545554
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.000545554	0.0545554
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.0545554
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.0545554
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000545554	0.0545554
FILIPPI SYNDROME	0.000545554	0.0545554
SRD5A3-CDG	0.000545554	0.0545554
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000545554	0.0545554
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.0545554
SENIOR-LOKEN SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.0545554
SEVERE CANAVAN DISEASE	0.000545554	0.0545554
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.000545554	0.0545554
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.0545554
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.0545554
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.000545554	0.0545554
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.000545554	0.0545554
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.0545554
PYRIDOXINE-DEPENDENT EPILEPSY	0.000545554	0.0545554
MEND SYNDROME; MEND	0.000545554	0.0545554
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.0545554
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.0545554
11P15.4 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
HEREDITARY OROTIC ACIDURIA	0.000545554	0.0545554
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.000545554	0.0545554
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.0545554
BARATELA-SCOTT SYNDROME	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.0545554
OXOGLUTARIC ACIDURIA	0.000545554	0.0545554
OGDEN SYNDROME; OGDNS	0.000545554	0.0545554
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.0545554
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.0545554
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.0545554
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.0545554
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.0545554
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.0545554
SAY-BARBER-MILLER SYNDROME	0.000545554	0.0545554
SARCOSINEMIA	0.000545554	0.0545554
RUVALCABA SYNDROME	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.0545554
ROBERTS SYNDROME	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.0545554
LATERAL MENINGOCELE SYNDROME	0.000545554	0.0545554
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000545554	0.0545554
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.0545554
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.000545554	0.0545554
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.0545554
KAGAMI-OGATA SYNDROME	0.000545554	0.0545554
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.0545554
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.0545554
ZEBRA BODY MYOPATHY	0.000545554	0.0545554
RIGID SPINE SYNDROME	0.000545554	0.0545554
BOHRING-OPITZ SYNDROME	0.000545554	0.0545554
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.0545554
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.0545554
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.0545554
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.0545554
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.0545554
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.000545554	0.0545554
CK SYNDROME	0.000545554	0.0545554
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.0545554
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.0545554
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.000545554	0.0545554
RECOMBINANT 8 SYNDROME	0.000545554	0.0545554
LOWRY-MACLEAN SYNDROME	0.000545554	0.0545554
OCULOECTODERMAL SYNDROME; OES	0.000545554	0.0545554
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.0545554
MONOSOMY 13Q34	0.000545554	0.0545554
BAND HETEROTOPIA; BH	0.000545554	0.0545554
EMANUEL SYNDROME	0.000545554	0.0545554
CODAS SYNDROME	0.000545554	0.0545554
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.0545554
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.0545554
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.0545554
CHROMOSOME 2Q37 DELETION SYNDROME	0.000545554	0.0545554
X SMALL RINGS	0.000545554	0.0545554
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.0545554
MIETENS SYNDROME	0.000545554	0.0545554
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.0545554
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.0545554
8P11.2 DELETION SYNDROME	0.000545554	0.0545554
ADAMS-OLIVER SYNDROME 1; AOS1	0.000545554	0.0545554
8P23.1 DUPLICATION SYNDROME	0.000545554	0.0545554
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.0545554
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
12Q14 MICRODELETION SYNDROME	0.000545554	0.0545554
CITRULLINEMIA TYPE II	0.000545554	0.0545554
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.0545554
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000545554	0.0545554
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
MOSAIC TRISOMY 9	0.000545554	0.0545554
LIG4 SYNDROME	0.000545554	0.0545554
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.0545554
RFT1-CDG	0.000545554	0.0545554
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.0545554
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.0545554
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.0545554
48,XYYY SYNDROME	0.000545554	0.0545554
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.0545554
6Q25 MICRODELETION SYNDROME	0.000545554	0.0545554
ANGELMAN SYNDROME	0.000545554	0.0545554
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.0545554
3Q29 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA TYPE 13	0.000545554	0.0545554
2Q31.1 MICRODELETION SYNDROME	0.000545554	0.0545554
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.0545554
MICRO SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000545554	0.0545554
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.0545554
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.0545554
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.0545554
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.0545554
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.0545554
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.0545554
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.0545554
16P11.2P12.2 MICRODELETION SYNDROME	0.000545554	0.0545554
16P13.11 MICRODELETION SYNDROME	0.000545554	0.0545554
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.0545554
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.0545554
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.0545554
OKAMOTO SYNDROME	0.000545554	0.0545554
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000545554	0.0545554
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000545554	0.0545554
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.0545554
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.0545554
HOLMES-GANG SYNDROME	0.000545554	0.0545554
KABUKI SYNDROME 1	0.000545554	0.0545554
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.0545554
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.0545554
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.0545554
BILATERAL POLYMICROGYRIA	0.000545554	0.0545554
WAISMAN SYNDROME; WSMN	0.000545554	0.0545554
PALLISTER-HALL SYNDROME	0.000545554	0.0545554
TARP SYNDROME; TARPS	0.000545554	0.0545554
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.0545554
HURLER SYNDROME	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.0545554
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.0545554
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000545554	0.0545554
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000545554	0.0545554
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000545554	0.0545554
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.0545554
KBG SYNDROME	0.000545554	0.0545554
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.0545554
ISOVALERIC ACIDEMIA	0.000545554	0.0545554
PFEIFFER SYNDROME TYPE 2	0.000545554	0.0545554
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000545554	0.0545554
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.0545554
L1 SYNDROME	0.000545554	0.0545554
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME TYPE 6	0.000545554	0.0545554
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.0545554
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.0545554
PELIZAEUS-MERZBACHER DISEASE	0.000545554	0.0545554
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.0545554
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.0545554
DISTAL MONOSOMY 6P	0.000545554	0.0545554
DISTAL MONOSOMY 19P13.3	0.000545554	0.0545554
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.000545554	0.0545554
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.0545554
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.0545554
DISTAL MONOSOMY 10Q	0.000545554	0.0545554
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.0545554
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000545554	0.0545554
20P12.3 MICRODELETION SYNDROME	0.000545554	0.0545554
TRISOMY 17P	0.000545554	0.0545554
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.0545554
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.0545554
DISTAL MONOSOMY 12Q	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.0545554
XP21 MICRODELETION SYNDROME	0.000545554	0.0545554
WIEACKER-WOLFF SYNDROME	0.000545554	0.0545554
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.0545554
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000545554	0.0545554
THYROID ECTOPIA	0.000545554	0.0545554
ATHYREOSIS	0.000545554	0.0545554
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.000545554	0.0545554
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.0545554
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000545554	0.0545554
COG4-CDG	0.000545554	0.0545554
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.0545554
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.0545554
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.0545554
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.0545554
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.0545554
THYROID HEMIAGENESIS	0.000545554	0.0545554
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000545554	0.0545554
THYROID HYPOPLASIA	0.000545554	0.0545554
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000545554	0.0545554
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.0545554
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
ALG3-CDG	0.000545554	0.0545554
PMM2-CDG	0.000545554	0.0545554
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.0545554
VICI SYNDROME; VICIS	0.000545554	0.0545554
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.0545554
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000545554	0.0545554
ALG6-CDG	0.000545554	0.0545554
ARIMA SYNDROME	0.000545554	0.0545554
KRABBE DISEASE	0.000545554	0.0545554
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.0545554
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.0545554
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.0545554
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.0545554
KETOADIPICACIDURIA	0.000545554	0.0545554
JOUBERT SYNDROME	0.000545554	0.0545554
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000545554	0.0545554
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000545554	0.0545554
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.000545554	0.0545554
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.0545554
BIOTINIDASE DEFICIENCY	0.000545554	0.0545554
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.0545554
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.0545554
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
HYDROXYKYNURENINURIA	0.000545554	0.0545554
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000545554	0.0545554
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.0545554
ARGININOSUCCINIC ACIDURIA	0.000545554	0.0545554
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.0545554
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
TRANSKETOLASE DEFICIENCY	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.0545554
ALSTROM SYNDROME; ALMS	0.000545554	0.0545554
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.0545554
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.0545554
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.0545554
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.0545554
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.0545554
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000545554	0.0545554
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.0545554
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.0545554
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000545554	0.0545554
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.0545554
GRISCELLI SYNDROME TYPE 1	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000545554	0.0545554
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.000545554	0.0545554
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.0545554
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000545554	0.0545554
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.0545554
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.0545554
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.0545554
LATHOSTEROLOSIS	0.000545554	0.0545554
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.0545554
MACDERMOT-WINTER SYNDROME	0.000545554	0.0545554
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.0545554
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000545554	0.0545554
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.0545554
CHAR SYNDROME	0.000545554	0.0545554
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000545554	0.0545554
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.0545554
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.000545554	0.0545554
INCONTINENTIA PIGMENTI	0.000545554	0.0545554
ALG1-CDG	0.000545554	0.0545554
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.0545554
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.0545554
MEHMO SYNDROME; MEHMO	0.000545554	0.0545554
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.0545554
CITRULLINEMIA, CLASSIC	0.000545554	0.0545554
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.0545554
COACH SYNDROME	0.000545554	0.0545554
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.0545554
MEDULLOBLASTOMA	0.000545554	0.0545554
ALPHA-MANNOSIDOSIS	0.000545554	0.0545554
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.0545554
MULTIPLE SULFATASE DEFICIENCY	0.000545554	0.0545554
NETHERTON SYNDROME	0.000545554	0.0545554
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000545554	0.0545554
COSTELLO SYNDROME; CSTLO	0.000545554	0.0545554
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.0545554
ATELOSTEOGENESIS TYPE III	0.000545554	0.0545554
RABSON-MENDENHALL SYNDROME	0.000545554	0.0545554
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.0545554
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.0545554
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.0545554
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.0545554
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.000545554	0.0545554
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000545554	0.0545554
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.0545554
JOUBERT SYNDROME 1	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.0545554
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.0545554
CEDNIK SYNDROME	0.000545554	0.0545554
WOLMAN DISEASE	0.000545554	0.0545554
LEBER CONGENITAL AMAUROSIS	0.000545554	0.0545554
C SYNDROME	0.000545554	0.0545554
NIEMANN-PICK DISEASE TYPE C	0.000545554	0.0545554
NARP SYNDROME	0.000545554	0.0545554
MARINESCO-SJÖGREN SYNDROME	0.000545554	0.0545554
MONOSOMY 9Q22.3	0.000545554	0.0545554
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.0545554
HYDROXYKYNURENINURIA	0.000545554	0.0545554
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000545554	0.0545554
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.0545554
GAUCHER DISEASE, TYPE II	0.000545554	0.0545554
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.0545554
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.0545554
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.0545554
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.0545554
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000545554	0.0545554
CRANIOPHARYNGIOMA	0.000545554	0.0545554
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.0545554
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.0545554
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.0545554
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.0545554
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000545554	0.0545554
HARTNUP DISORDER	0.000545554	0.0545554
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.0545554
FOLATE MALABSORPTION, HEREDITARY	0.000545554	0.0545554
AICARDI-GOUTIÈRES SYNDROME	0.000545554	0.0545554
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.0545554
MAPLE SYRUP URINE DISEASE	0.000545554	0.0545554
WYBURN-MASON SYNDROME	0.000545554	0.0545554
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.0545554
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000545554	0.0545554
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000545554	0.0545554
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.0545554
PEDIATRIC-ONSET GRAVES DISEASE	0.000545554	0.0545554
RUBINSTEIN-TAYBI SYNDROME	0.000545554	0.0545554
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.000545554	0.0545554
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000545554	0.0545554
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.0545554
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000545554	0.0545554
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.0545554
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.0545554
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.0545554
JAWAD SYNDROME	0.000545554	0.0545554
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.0545554
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.0545554
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.0545554
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.0545554
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.0545554
SYNDROMIC DIARRHEA	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.0545554
TAY-SACHS DISEASE	0.000545554	0.0545554
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.0545554
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
DISTAL MONOSOMY 1Q	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000545554	0.0545554
19P13.13 MICRODELETION SYNDROME	0.000545554	0.0545554
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.0545554
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.0545554
SLC35A2-CDG	0.000545554	0.0545554
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.0545554
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.0545554
20Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
SULFOCYSTEINURIA	0.000545554	0.0545554
19P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.000545554	0.0545554
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.0545554
ROTHMUND-THOMSON SYNDROME	0.000545554	0.0545554
SSR4-CDG	0.000545554	0.0545554
STT3B-CDG	0.000545554	0.0545554
STT3A-CDG	0.000545554	0.0545554
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.0545554
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.0545554
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.0545554
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.0545554
FREE SIALIC ACID STORAGE DISEASE	0.000545554	0.0545554
INFANTILE SIALIC ACID STORAGE DISEASE	0.000545554	0.0545554
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.000545554	0.0545554
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.0545554
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.0545554
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.0545554
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.0545554
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.0545554
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.0545554
GENITOPATELLAR SYNDROME	0.000545554	0.0545554
WAARDENBURG-SHAH SYNDROME	0.000545554	0.0545554
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.0545554
TRISOMY X	0.000545554	0.0545554
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.0545554
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.0545554
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.0545554
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.0545554
TRICHOTHIODYSTROPHY	0.000545554	0.0545554
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.0545554
FARBER DISEASE	0.000545554	0.0545554
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.0545554
KEUTEL SYNDROME	0.000545554	0.0545554
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000545554	0.0545554
TETRASOMY 5P	0.000545554	0.0545554
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.0545554
DISTAL TRISOMY 17Q	0.000545554	0.0545554
TRISOMY 18	0.000545554	0.0545554
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.0545554
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.0545554
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.0545554
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.0545554
GALACTOSEMIA	0.000545554	0.0545554
EPIDERMAL NEVUS SYNDROME	0.000545554	0.0545554
ISOLATED PLAGIOCEPHALY	0.000545554	0.0545554
PROPIONIC ACIDEMIA	0.000545554	0.0545554
FUCOSIDOSIS	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME VI	0.000545554	0.0545554
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.0545554
SEPTOOPTIC DYSPLASIA	0.000545554	0.0545554
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.000545554	0.0545554
WILSON-TURNER SYNDROME	0.000545554	0.0545554
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.0545554
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.0545554
WEAVER SYNDROME	0.000545554	0.0545554
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000545554	0.0545554
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.0545554
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.000545554	0.0545554
PHACE SYNDROME	0.000545554	0.0545554
SCHIZENCEPHALY	0.000545554	0.0545554
COG2-CDG	0.000545554	0.0545554
ELEJALDE DISEASE	0.000545554	0.0545554
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000545554	0.0545554
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.0545554
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000545554	0.0545554
NAVAJO NEUROHEPATOPATHY	0.000545554	0.0545554
DYSTONIA-APHONIA SYNDROME	0.000545554	0.0545554
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.0545554
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.0545554
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.0545554
LISSENCEPHALY 2; LIS2	0.000545554	0.0545554
RIDDLE SYNDROME	0.000545554	0.0545554
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.0545554
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.000545554	0.0545554
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.000545554	0.0545554
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000545554	0.0545554
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.0545554
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.0545554
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.0545554
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000545554	0.0545554
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.000545554	0.0545554
MUCOLIPIDOSIS IV; ML4	0.000545554	0.0545554
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000545554	0.0545554
CONGENITAL HYPOTHYROIDISM	0.000545554	0.0545554
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000545554	0.0545554
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.0545554
LEIGH SYNDROME; LS	0.000545554	0.0545554
NETHERTON SYNDROME; NETH	0.000545554	0.0545554
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.0545554
OROTIC ACIDURIA	0.000545554	0.0545554
SMITH-MAGENIS SYNDROME	0.000545554	0.0545554
PYRUVATE CARBOXYLASE DEFICIENCY	0.000545554	0.0545554
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.0545554
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.0545554
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.0545554
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.0545554
DIGEORGE SYNDROME; DGS	0.000545554	0.0545554
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000545554	0.0545554
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.0545554
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.0545554
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.0545554
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.0545554
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.0545554
GRISCELLI SYNDROME	0.000545554	0.0545554
REVESZ SYNDROME	0.000545554	0.0545554
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.0545554
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.0545554
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.0545554
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.0545554
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.0545554
RAINE SYNDROME	0.000545554	0.0545554
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000545554	0.0545554
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.0545554
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.0545554
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.000545554	0.0545554
PEHO SYNDROME; PEHO	0.000545554	0.0545554
PELLAGRA-LIKE SYNDROME	0.000545554	0.0545554
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.0545554
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.000545554	0.0545554
MEND SYNDROME	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000545554	0.0545554
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.0545554
CURRY-JONES SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.0545554
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000545554	0.0545554
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.0545554
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.0545554
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.0545554
EVEN-PLUS SYNDROME	0.000545554	0.0545554
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.0545554
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.0545554
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.0545554
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.0545554
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000545554	0.0545554
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.000545554	0.0545554
LAMB-SHAFFER SYNDROME	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.0545554
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.0545554
JOUBERT SYNDROME 26	0.000545554	0.0545554
JOUBERT SYNDROME 25	0.000545554	0.0545554
SECKEL SYNDROME 9; SCKL9	0.000545554	0.0545554
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.0545554
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.000545554	0.0545554
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.0545554
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.0545554
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.0545554
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.0545554
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.0545554
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.0545554
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000545554	0.0545554
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.0545554
COFFIN-SIRIS SYNDROME 5	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.0545554
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.0545554
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.0545554
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.0545554
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.0545554
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.0545554
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.0545554
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.000545554	0.0545554
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000545554	0.0545554
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.0545554
NOONAN SYNDROME 9; NS9	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.0545554
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.0545554
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.0545554
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.0545554
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.0545554
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.0545554
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.0545554
AL-RAQAD SYNDROME; ARS	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000545554	0.0545554
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.0545554
AU-KLINE SYNDROME; AUKS	0.000545554	0.0545554
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.0545554
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.0545554
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.0545554
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000545554	0.0545554
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000545554	0.0545554
DESANTO-SHINAWI SYNDROME	0.000545554	0.0545554
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.0545554
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.0545554
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000545554	0.0545554
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000545554	0.0545554
JOUBERT SYNDROME 24	0.000545554	0.0545554
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.0545554
ROIFMAN SYNDROME; RFMN	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.0545554
SENIOR-LOKEN SYNDROME 9	0.000545554	0.0545554
RING CHROMOSOME 14 SYNDROME	0.000545554	0.0545554
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.000545554	0.0545554
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.0545554
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.0545554
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.0545554
PEHO-LIKE SYNDROME; PEHOL	0.000545554	0.0545554
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000545554	0.0545554
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.0545554
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.0545554
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.0545554
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.0545554
RAHMAN SYNDROME	0.000545554	0.0545554
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.0545554
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.0545554
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000545554	0.0545554
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.0545554
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.0545554
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.000545554	0.0545554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000545554	0.0545554
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000545554	0.0545554
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.0545554
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.0545554
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000545554	0.0545554
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.0545554
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000545554	0.0545554
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.0545554
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000545554	0.0545554
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.0545554
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.0545554
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.0545554
MECKEL SYNDROME 13; MKS13	0.000545554	0.0545554
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.0545554
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.0545554
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.0545554
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000545554	0.0545554
HAREL-YOON SYNDROME; HAYOS	0.000545554	0.0545554
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.0545554
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000545554	0.0545554
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.0545554
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.0545554
ZTTK SYNDROME; ZTTKS	0.000545554	0.0545554
ALAZAMI-YUAN SYNDROME	0.000545554	0.0545554
SHASHI-PENA SYNDROME; SHAPNS	0.000545554	0.0545554
JOUBERT SYNDROME 28	0.000545554	0.0545554
JOUBERT SYNDROME 27	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.0545554
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.0545554
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000545554	0.0545554
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000545554	0.0545554
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.0545554
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000545554	0.0545554
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.000545554	0.0545554
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.000545554	0.0545554
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.0545554
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.0545554
OPTIC ATROPHY 11; OPA11	0.000545554	0.0545554
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.0545554
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.0545554
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000545554	0.0545554
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.0545554
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.0545554
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000545554	0.0545554
LISSENCEPHALY 8; LIS8	0.000545554	0.0545554
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.0545554
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000545554	0.0545554
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.0545554
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.0545554
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.0545554
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.0545554
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000545554	0.0545554
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.0545554
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000545554	0.0545554
STEEL SYNDROME; STLS	0.000545554	0.0545554
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.0545554
TYSHCHENKO SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.0545554
ALAZAMI SYNDROME; ALAZS	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.000545554	0.0545554
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.0545554
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.0545554
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
ADAMS-OLIVER SYNDROME 2; AOS2	0.000545554	0.0545554
SCHAAF-YANG SYNDROME; SHFYNG	0.000545554	0.0545554
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.0545554
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.0545554
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.0545554
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.0545554
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.0545554
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.0545554
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.0545554
INFANTILE LIVER FAILURE SYNDROME 1	0.000545554	0.0545554
HOLOPROSENCEPHALY 11	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.0545554
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.0545554
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000545554	0.0545554
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.0545554
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.0545554
CHOPS SYNDROME; CHOPS	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000545554	0.0545554
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.0545554
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.0545554
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.0545554
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000545554	0.0545554
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.0545554
PONTINE TEGMENTAL CAP DYSPLASIA	0.000545554	0.0545554
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.0545554
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.0545554
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.0545554
COFFIN-SIRIS SYNDROME 4; CSS4	0.000545554	0.0545554
COFFIN-SIRIS SYNDROME 3; CSS3	0.000545554	0.0545554
COFFIN-SIRIS SYNDROME 2; CSS2	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000545554	0.0545554
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.0545554
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.0545554
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000545554	0.0545554
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000545554	0.0545554
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.0545554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.0545554
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.000545554	0.0545554
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.000545554	0.0545554
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.0545554
JOUBERT SYNDROME 14	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.0545554
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.0545554
JOUBERT SYNDROME 15	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000545554	0.0545554
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.0545554
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.0545554
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.0545554
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.0545554
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000545554	0.0545554
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.0545554
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.0545554
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.0545554
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.0545554
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.0545554
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.0545554
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.0545554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.0545554
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.0545554
LISSENCEPHALY 4	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000545554	0.0545554
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.0545554
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000545554	0.0545554
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.0545554
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.0545554
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.000545554	0.0545554
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000545554	0.0545554
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.0545554
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.000545554	0.0545554
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.0545554
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.0545554
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.0545554
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.0545554
SECKEL SYNDROME 8; SCKL8	0.000545554	0.0545554
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000545554	0.0545554
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000545554	0.0545554
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.0545554
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.0545554
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.0545554
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.0545554
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000545554	0.0545554
CHROMOSOME 5Q12 DELETION SYNDROME	0.000545554	0.0545554
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.0545554
JOUBERT SYNDROME 21	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.0545554
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
XIA-GIBBS SYNDROME	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.0545554
BARDET-BIEDL SYNDROME 2	0.000545554	0.0545554
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.0545554
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.0545554
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.0545554
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.0545554
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000545554	0.0545554
CULLER-JONES SYNDROME; CJS	0.000545554	0.0545554
AICARDI-GOUTIERES SYNDROME 7	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000545554	0.0545554
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.0545554
NOONAN SYNDROME 6; NS6	0.000545554	0.0545554
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.0545554
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.0545554
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.0545554
CHÉDIAK-HIGASHI SYNDROME	0.000545554	0.0545554
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.0545554
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.0545554
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.0545554
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.000545554	0.0545554
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.0545554
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.0545554
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000545554	0.0545554
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000545554	0.0545554
2P21 MICRODELETION SYNDROME	0.000545554	0.0545554
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.0545554
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.0545554
EMANUEL SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.0545554
MONOSOMY 18Q	0.000545554	0.0545554
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.0545554
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.000545554	0.0545554
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000545554	0.0545554
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.0545554
LARSEN-LIKE SYNDROME	0.000545554	0.0545554
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.0545554
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.0545554
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.0545554
LISSENCEPHALY 1; LIS1	0.000545554	0.0545554
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.0545554
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.0545554
TEMTAMY SYNDROME	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.0545554
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.0545554
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.0545554
JOUBERT SYNDROME 2	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000545554	0.0545554
DISTAL TRISOMY 6P	0.000545554	0.0545554
KAGAMI-OGATA SYNDROME	0.000545554	0.0545554
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.0545554
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.0545554
DISTAL TRISOMY 18Q	0.000545554	0.0545554
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.0545554
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.0545554
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000545554	0.0545554
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000545554	0.0545554
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.0545554
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000545554	0.0545554
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.0545554
AURICULOCONDYLAR SYNDROME	0.000545554	0.0545554
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.0545554
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.0545554
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.0545554
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.0545554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000545554	0.0545554
CARDIOFACIOCUTANEOUS SYNDROME	0.000545554	0.0545554
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000545554	0.0545554
17Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000545554	0.0545554
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.0545554
AYMÉ-GRIPP SYNDROME	0.000545554	0.0545554
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.0545554
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.0545554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.000545554	0.0545554
MEVALONIC ACIDURIA; MEVA	0.000545554	0.0545554
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.0545554
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.0545554
NOONAN SYNDROME 3; NS3	0.000545554	0.0545554
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.0545554
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.0545554
SCHINDLER DISEASE, TYPE I	0.000545554	0.0545554
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000545554	0.0545554
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.0545554
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.0545554
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.0545554
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000545554	0.0545554
VICI SYNDROME	0.000545554	0.0545554
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.0545554
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.0545554
COFFIN-SIRIS SYNDROME	0.000545554	0.0545554
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000545554	0.0545554
CODAS SYNDROME	0.000545554	0.0545554
CINCA SYNDROME	0.000545554	0.0545554
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.0545554
CHROMOSOME 10Q26 DELETION SYNDROME	0.000545554	0.0545554
RING CHROMOSOME 12 SYNDROME	0.000545554	0.0545554
XQ21 MICRODELETION SYNDROME	0.000545554	0.0545554
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.0545554
CANAVAN DISEASE	0.000545554	0.0545554
FRIAS SYNDROME	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.0545554
AL KAISSI SYNDROME; ALKAS	0.000545554	0.0545554
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.0545554
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.0545554
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.0545554
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.0545554
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.0545554
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.0545554
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.0545554
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.0545554
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.0545554
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.0545554
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
HYPERTRICHOSIS CUBITI	0.000545554	0.0545554
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.0545554
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.0545554
MATERNAL PHENYLKETONURIA	0.000545554	0.0545554
JOUBERT SYNDROME WITH RENAL DEFECT	0.000545554	0.0545554
JOUBERT SYNDROME WITH OCULAR DEFECT	0.000545554	0.0545554
SALLA DISEASE	0.000545554	0.0545554
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.0545554
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.0545554
ICF SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000545554	0.0545554
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000545554	0.0545554
KBG SYNDROME	0.000545554	0.0545554
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.0545554
1Q44 MICRODELETION SYNDROME	0.000545554	0.0545554
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.0545554
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.0545554
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.0545554
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.0545554
MUENKE SYNDROME	0.000545554	0.0545554
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.0545554
TRISOMY 9P	0.000545554	0.0545554
DUANE RETRACTION SYNDROME	0.000545554	0.0545554
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.0545554
USHER SYNDROME TYPE 1	0.000545554	0.0545554
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000545554	0.0545554
JACOBSEN SYNDROME	0.000545554	0.0545554
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.0545554
MICROVILLUS INCLUSION DISEASE	0.000545554	0.0545554
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.0545554
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.0545554
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.0545554
BOHRING-OPITZ SYNDROME	0.000545554	0.0545554
HYDRANENCEPHALY	0.000545554	0.0545554
HURLER SYNDROME	0.000545554	0.0545554
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.0545554
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME	0.000545554	0.0545554
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000545554	0.0545554
COLE-CARPENTER SYNDROME	0.000545554	0.0545554
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.0545554
FLOATING-HARBOR SYNDROME	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.0545554
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.0545554
EAST SYNDROME	0.000545554	0.0545554
OCCIPITAL HORN SYNDROME	0.000545554	0.0545554
GERMAN SYNDROME	0.000545554	0.0545554
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.0545554
PHACE ASSOCIATION	0.000545554	0.0545554
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.0545554
LIG4 SYNDROME	0.000545554	0.0545554
FUMARASE DEFICIENCY; FMRD	0.000545554	0.0545554
COHEN SYNDROME	0.000545554	0.0545554
TOLUENE EMBRYOPATHY	0.000545554	0.0545554
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.0545554
FETAL HYDANTOIN SYNDROME	0.000545554	0.0545554
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.0545554
GERODERMA OSTEODYSPLASTICA	0.000545554	0.0545554
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.0545554
DONNAI-BARROW SYNDROME	0.000545554	0.0545554
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.0545554
ZECHI-CEIDE SYNDROME	0.000545554	0.0545554
NOONAN SYNDROME 2; NS2	0.000545554	0.0545554
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000545554	0.0545554
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.0545554
HOLOPROSENCEPHALY	0.000545554	0.0545554
FRONTOOCULAR SYNDROME	0.000545554	0.0545554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.0545554
PROPIONIC ACIDEMIA	0.000545554	0.0545554
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.0545554
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000545554	0.0545554
HARTNUP DISEASE	0.000545554	0.0545554
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.0545554
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000545554	0.0545554
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.0545554
CUTIS LAXA	0.000545554	0.0545554
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.0545554
OPTIC PATHWAY GLIOMA	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.0545554
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000545554	0.0545554
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.0545554
COFFIN-SIRIS SYNDROME 7; CSS7	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.0545554
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.0545554
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000545554	0.0545554
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.0545554
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.0545554
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.0545554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.000545554	0.0545554
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.0545554
JABERI-ELAHI SYNDROME; JABELS	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000545554	0.0545554
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.0545554
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.0545554
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.0545554
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000545554	0.0545554
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.0545554
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000545554	0.0545554
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.0545554
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.0545554
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.0545554
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.0545554
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000545554	0.0545554
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.0545554
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.0545554
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.0545554
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000545554	0.0545554
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.0545554
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.0545554
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.0545554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.0545554
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.0545554
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.0545554
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000545554	0.0545554
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.0545554
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.0545554
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.0545554
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.0545554
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000545554	0.0545554
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000545554	0.0545554
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.0545554
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.0545554
CHROMOSOME 1P35 DELETION SYNDROME	0.000545554	0.0545554
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000545554	0.0545554
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000545554	0.0545554
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000545554	0.0545554
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000545554	0.0545554
HADZISELIMOVIC SYNDROME	0.000545554	0.0545554
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000545554	0.0545554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.0545554
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000545554	0.0545554
COFFIN-SIRIS SYNDROME 6; CSS6	0.000545554	0.0545554
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.0545554
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.0545554
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000545554	0.0545554
NOONAN SYNDROME 11; NS11	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000545554	0.0545554
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000545554	0.0545554
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.000545554	0.0545554
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000545554	0.0545554
NOONAN SYNDROME 5; NS5	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.0545554
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000545554	0.0545554
JOUBERT SYNDROME 7	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.0545554
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.0545554
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.0545554
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.0545554
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.0545554
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.0545554
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.0545554
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.0545554
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.0545554
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000545554	0.0545554
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
CHROMOSOME 16P13.3 DELETION SYNDROME	0.000545554	0.0545554
PENTASOMY X	0.000545554	0.0545554
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.0545554
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000545554	0.0545554
JOUBERT SYNDROME 6	0.000545554	0.0545554
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.0545554
TRANSALDOLASE DEFICIENCY	0.000545554	0.0545554
CORNELIA DE LANGE SYNDROME 3	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.0545554
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.000545554	0.0545554
HOLOPROSENCEPHALY 7	0.000545554	0.0545554
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.0545554
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.0545554
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.0545554
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.0545554
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.0545554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.0545554
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000545554	0.0545554
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.0545554
JOUBERT SYNDROME 8	0.000545554	0.0545554
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.0545554
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.0545554
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.0545554
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000545554	0.0545554
GLASS SYNDROME	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.0545554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.0545554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000545554	0.0545554
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000545554	0.0545554
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.0545554
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.0545554
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.0545554
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.0545554
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.0545554
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.0545554
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.0545554
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000545554	0.0545554
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.0545554
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.0545554
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.0545554
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000545554	0.0545554
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.0545554
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.0545554
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.0545554
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.0545554
